Scilex Holding Company
Scilex Holding Company (SCLX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
sclx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Scilex Holding Company (SCLX) measures how much investors pay for each dollar of the company's trailing earnings. SCLX's current PE ratio of N/A is calculated by dividing its stock price of $6.91 by its TTM earnings per share of -$60.90.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - General · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Scilex Holding CompanyYou SCLX | $59M | N/A | — | -$60.90 |
 Acumen Pharmaceuticals, Inc. ABOS | $131M | N/A | — | -$2.00 |
 Agenus Inc. AGEN | $131M | 811.87x | — | $0.00 |
 Alector, Inc. ALEC | $182M | N/A | — | -$1.39 |
 Citius Oncology, Inc. CTOR | $74M | N/A | — | -$0.34 |
 Inovio Pharmaceuticals, Inc. INO | $58M | N/A | — | -$0.18 |
 Opus Genetics, Inc. IRD | $328M | N/A | — | -$0.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-32.51 | — | |
2024-12-31 FY2024 | — | $-10.47 | — | |
2023-12-31 FY2023 | — | $-30.71 | — | |
2022-12-31 FY2022 | — | $-6.09 | — | |
2021-12-31 FY2021 | — | $-23.30 | — | |
2020-12-31 FY2020 | — | $-11.79 | — | |
2019-12-31 FY2019 | — | $-44.30 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Scilex Holding Company (SCLX) measures how much investors pay for each dollar of the company's trailing earnings. SCLX's current PE ratio of N/A is calculated by dividing its stock price of $6.91 by its TTM earnings per share of -$60.90.
Frequently asked questions
SCLX pe ratio · 6 questionsSCLX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $6.91 and TTM EPS of -$60.90. Data sourced from Financial Modeling Prep via SCLX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Scilex Holding Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09